dextroamphetamine has been researched along with Fatigue Syndrome, Chronic in 6 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To present two other dermatologic conditions related to a disorder of sympathetic nervous system hypofunction common in women that respond to treatment with dextroamphetamine sulfate--chronic eczema and keratosis pilaris." | 7.80 | Complete eradication of chronic long standing eczema and keratosis pilaris following treatment with dextroamphetamine sulfate. ( Chan, S; Check, JH, 2014) |
| "Dextroamphetamine sulfate 15-mg extended release capsules were given to women with a variety of treatment refractory conditions including, but not limited to, pelvic pain." | 3.81 | Sympathomimetic amines are a safe, highly effective therapy for several female chronic disorders that do not respond well to conventional therapy. ( Check, JH, 2015) |
| "To present two other dermatologic conditions related to a disorder of sympathetic nervous system hypofunction common in women that respond to treatment with dextroamphetamine sulfate--chronic eczema and keratosis pilaris." | 3.80 | Complete eradication of chronic long standing eczema and keratosis pilaris following treatment with dextroamphetamine sulfate. ( Chan, S; Check, JH, 2014) |
| "Dextroamphetamine sulfate 15 mg extended release capsule was prescribed to a woman with a 25 year history of MELAS syndrome refractory to most other therapies." | 3.80 | Improvement in symptoms of the syndrome of mitochondrial encephalopathy, lactic acidosis, and stroke-like symptoms (MELAS) following treatment with sympathomimetic amines--possible implications for improving fecundity in women of advanced reproductive age ( Check, JH; Mitchell-Williams, J; Potestio, CP, 2014) |
| "These cases suggest that ADHD and chronic fatigue syndrome (and possibly fibromyalgia) share a common underlying mechanism." | 1.39 | Chronic fatigue syndrome: 3 cases and a discussion of the natural history of attention-deficit/hyperactivity disorder. ( Young, JL, 2013) |
| "To show that chronic fatigue syndrome can be mistakenly attributed to Lyme disease rather than considering sympathetic neural hyperalgesia edema syndrome." | 1.37 | Sympathetic neural hyperalgesia edema syndrome, a frequent cause of pelvic pain in women, mistaken for Lyme disease with chronic fatigue. ( Check, JH; Cohen, R, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Check, JH | 4 |
| Chan, S | 1 |
| Potestio, CP | 1 |
| Mitchell-Williams, J | 1 |
| Cohen, R | 1 |
| Young, JL | 2 |
1 trial available for dextroamphetamine and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: a double blind, placebo-controlled study.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Cognition Disorders; Dextroamphetamine; Dose-Resp | 2013 |
5 other studies available for dextroamphetamine and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Complete eradication of chronic long standing eczema and keratosis pilaris following treatment with dextroamphetamine sulfate.
Topics: Abnormalities, Multiple; Chronic Disease; Darier Disease; Dextroamphetamine; Eczema; Eyebrows; Fatig | 2014 |
Improvement in symptoms of the syndrome of mitochondrial encephalopathy, lactic acidosis, and stroke-like symptoms (MELAS) following treatment with sympathomimetic amines--possible implications for improving fecundity in women of advanced reproductive age
Topics: Adult; Central Nervous System Stimulants; Chronic Pain; Dextroamphetamine; Edema; Fatigue Syndrome, | 2014 |
Sympathomimetic amines are a safe, highly effective therapy for several female chronic disorders that do not respond well to conventional therapy.
Topics: Central Nervous System Stimulants; Chronic Disease; Cystitis, Interstitial; Dextroamphetamine; Fatig | 2015 |
Sympathetic neural hyperalgesia edema syndrome, a frequent cause of pelvic pain in women, mistaken for Lyme disease with chronic fatigue.
Topics: Adult; Central Nervous System Stimulants; Dextroamphetamine; Diagnosis, Differential; Fatigue Syndro | 2011 |
Chronic fatigue syndrome: 3 cases and a discussion of the natural history of attention-deficit/hyperactivity disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphe | 2013 |